Lobbying registration dated 2026-04-02
Registrant: Martin Arès
Client: Apotex Inc.
Targeted institutions:
Global Affairs Canada (GAC)
House of Commons
Prime Minister's Office (PMO)
Public Services and Procurement Canada (PSPC)
Public Health Agency of Canada (PHAC)
Health Canada (HC)
Patented Medicine Prices Review Board (PMPRB)
Immigration, Refugees and Citizenship Canada (IRCC)
Innovation, Science and Economic Development Canada (ISED)
Government funding received:
Lobbying activity details:
Domestic pharmaceutical manufacturing: trade, tariffs, and sustainability of domestic manufacturing.
Pharmaceutical research & development -support for R&D in Canada.
Pharmaceutical policy: Ongoing interactions related to increased and sustainable utilization of cost-saving generic and biosimilar medicines, and a predictable and viable business environment for generic medicines.